Breathe Well Live Well
|
Stepping down asthma meds can be safe
Clinical Advisor Patients with asthma that is well-controlled by their current level of medication can step down their treatments safely, while at same time reducing the cost of therapy, according to a study published online ahead of print October 21 in the Journal of … |
View full post on asthma – Google News
|
Stepping down asthma meds can control exacerbations, costs
ModernMedicine Asthma management is expensive, but a new study reveals that stepping down asthma medications can be done safely and without any more complications than others with asthma face. “In patients who have had stable asthma for at least one year, stepping … |
View full post on asthma – Google News
Newsday |
Study looks at stepping down asthma medicines
Newsday Stepping down asthma medicines can be done safely and at a lower cost for patients, says a new Mayo Clinic study published recently in The Journal of Allergy and Clinical Immunology. It is common for patients and doctors to test if taking less daily … Home-based educational intervention improves asthma among Hispanic children American College of Allergy, Asthma & Immunology, Nov. 5-9 |
View full post on asthma – Google News
|
Stepping down on asthma medicines is viable option
azcentral.com Answer: Sometimes patients and their healthcare team may want to test out if taking less daily asthma medicine is safe. Trying to reduce daily asthma medicine use in asthma patients speaks to the principle of using the least amount of medicine to … |
View full post on asthma – Google News
Medical News Today |
Stepping down asthma medication is safe with guidance
Medical News Today To address this gap in information, lead author Dr. Matthew Rank, an allergy and immunology specialist at the Mayo Clinic in Arizona, and colleagues compared outcomes of a group of patients who stepped down their asthma medication against an … |
View full post on asthma – Google News
|
Demographic Characteristics of Asthma Subjects Associated With Stepping Down …
AJMC.com Managed Markets Network Methods: Subjects were included if they: 1) had ?2 FSC prescription claims prior to the index (step-down) date, 2) had ?1 asthma claim, 3) were aged 12 to 64 years, and 4) were continuously eligible for 12 months pre- and post index. Subjects were … |
View full post on asthma – Google News
Condition: Asthma
Intervention: Drug: Asthma medication reduuction
Sponsors: Kuopio University Hospital; Kuopio University Hospital
Recruiting – verified October 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days